Highlights Granules India Limited NSE India S.E.

Equities

GRANULES

INE101D01020

Market Closed - NSE India S.E. Other stock markets 05:13:52 13/05/2024 pm IST			5-day change	1st Jan Change
405.2 ^INR	+1.80%		-4.29%	-0.06%

30/04	Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares	MT
15/04	Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit	15/04	MT
Granules India Unit Gets VAI Status for Virginia Facility	03/04	MT
Paracetamol maker Granules India posts marginal rise in Q3 profit	23/01	RE
Granules India's Posts Gains in Fiscal Q3 Consolidated Net Profit	23/01	MT
Granules India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01	CI
Granules Pharmaceuticals Unit's Virginia Facility Gets Five Observations from US FDA	18/12	MT
Granules India Gets US FDA Nod for Pantoprazole Sodium Delayed-Release Tablets	13/12	MT
Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets	13/12	CI
Granules India Arm Gets US FDA Nod for Sildenafil for Oral Suspension	04/12	MT
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	09/11	RE
Granules India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11	CI
Granules India Limited Receives ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules	19/23/19	CI
Indian paracetamol maker Valiant Laboratories lists at 16% premium	06/23/06	RE
Granules India Gets US FDA Nod for Hypertension Treatment Drug	02/23/02	MT
Granules India Limited Announces the US Food & Drug Administration Approval of its Abbreviated New Drug Application for Losartan Potassium and Hydrochlorothiazide Tablets USP	30/23/30	CI
Granules India's Telangana Facility Gets Accreditation from Japanese Regulator	25/23/25	MT
Granules India Limited Receives Approval from Brazilian Health Regulatory Agency	24/23/24	CI
Granules India Limited Receives Accreditation Certificate of Foreign Drug Manufacturer from Pharmaceuticals and Medical Devices Agency	24/23/24	CI
Granules India Limited Approves Final Dividend for the Fiscal Year 2022-2023	10/23/10	CI
Paracetamol maker Granules India' Q1 profit hurt by cyber attack disruptions	09/23/09	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Granules India Limited NSE India S.E.

Equities

GRANULES

INE101D01020

Highlights

Filters